Close Menu

NEW YORK (GenomeWeb) – Sophia Genetics, a developer of bioinformatics for analyzing genetic test data, today said that it has raised $13.75 million in a Series B financing round.

The Lausanne, Switzerland-based company offers a software as a service called dropGen, which provides bioinformatic analyis, the validation and quality control process, and the presentation of genetic test results to clinicians while protecting patient DNA sequence data through safe storage and banking, it said.

The financing round was led by Invoke Capital, Swisscom, and Endeavour Vision.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.

May
07
Sponsored by
Agilent

This webinar will discuss the implementation of an enterprise-wide clinical genomics platform that is shared across 10 hospitals and research organizations in the Australian State of Victoria.

Jun
17
Sponsored by
Illumina

This webinar will provide an overview of polygenic risk scores, which aggregate dozens of genetic variants that have been linked to disease risk in genome-wide association studies (GWAS) into a single score.